Life Biosciences has raised $80m in a Series D financing [...]

Complement Therapeutics doses first patient in Phase 1/Phase 2 Opti-GAIN [...]

Circio Holding ASA, a biotechnology company developing circular RNA-based gene [...]

Link Biologics has appointed Niall Martin to its board as [...]

Axol Bioscience has acquired the ophthalmology business of Newcells Biotech, [...]

Breye Therapeutics has presented Phase 1b clinical data for its [...]

nordic-pharma-lacrifill-europe-launch Nordic Pharma has launched Lacrifill, a canalicular gel therapy [...]

PulseSight Therapeutics has completed dosing in its Phase 1 clinical [...]

AAVantgarde Bio has completed enrollment in LUCE-1, a first-in-human Phase [...]

The age-related macular degeneration market across the seven major markets [...]